|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:activities
|
gptkb:fragrance
|
|
gptkbp:appointed_by
|
injection
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Adrucil
Carac
Efudex
|
|
gptkbp:class
|
pyrimidine analog
|
|
gptkbp:clinical_trial
|
Phase IV
Phase II
Phase III
Phase I
|
|
gptkbp:contraindication
|
pregnancy
breastfeeding
|
|
gptkbp:developed_by
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:discovered_by
|
gptkb:1957
|
|
gptkbp:dissolved
|
water-soluble
|
|
gptkbp:dosage_form
|
500 mg/m2
1000 mg/m2
2000 mg/m2
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:financial_performance
|
light-sensitive
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
fluorouracil
|
|
gptkbp:ingredients
|
C4 H3 F N2 O2
|
|
gptkbp:interacts_with
|
gptkb:methotrexate
gptkb:leucovorin
gptkb:warfarin
|
|
gptkbp:is_used_for
|
treating cancer
|
|
gptkbp:lifespan
|
10 to 20 minutes
|
|
gptkbp:manager
|
intravenous
topical
|
|
gptkbp:research_areas
|
toxicology
drug development
oncology
pharmacology
clinical research
|
|
gptkbp:side_effect
|
nausea
vomiting
diarrhea
mouth sores
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:targets
|
gptkb:healthcare_organization
stomach cancer
|
|
gptkbp:bfsParent
|
gptkb:FOLFIRINOX
gptkb:leucovorin
|
|
gptkbp:bfsLayer
|
5
|